For example, β1 integrin silencing in human NSCLC A549 cells showed a defective activation of the EGFR signaling cascade, resulting in enhanced sensitivity to Gefitinib and cisplatin, reduced migration, and invasive behavior, and decreased in vitro proliferation and in vivo tumor growth. Here, EGFR is linked to non-small cell lung carcinoma.